Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update

Demirer, 2008, Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors., Nat Clin Pract Oncol, 5, 256, 10.1038/ncponc1104 Marie-Cardine, 2008, Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation., Clin Immunol, 127, 14, 10.1016/j.clim.2007.11.013 Tomblyn, 2009, Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective., Biol Blood Marrow Transplant, 15, 1143, 10.1016/j.bbmt.2009.06.019 Martino, 2006, Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation., Blood, 108, 2928, 10.1182/blood-2006-03-008706 Tramsen, 2009, Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy., Bone Marrow Transplant, 43, 13, 10.1038/bmt.2008.271 Ljungman, 2008, CMV infections after hematopoietic stem cell transplantation., Bone Marrow Transplant, 42, S70, 10.1038/bmt.2008.120 Gratama, 2001, Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection., Blood, 98, 1358, 10.1182/blood.V98.5.1358 Jakubowski, 2007, T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin., Blood, 110, 4552, 10.1182/blood-2007-06-093880 Zakrzewski, 2007, Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic stem cell transplantation., J Mol Med, 85, 837, 10.1007/s00109-007-0175-4 Chen, 2006, Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders., Bone Marrow Transplant, 38, 437, 10.1038/sj.bmt.1705468 Jiménez, 2007, Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens., Leukemia, 21, 1628, 10.1038/sj.leu.2404681 Dorshkind, 2009, The ageing immune system: is it ever too old to become young again?, Nat Rev Immunol, 9, 57, 10.1038/nri2471 Kollman, 2001, Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age., Blood, 98, 2043, 10.1182/blood.V98.7.2043 Fujimaki, 2001, Immune reconstitution assessed during five years after allogeneic bone marrow transplantation., Bone Marrow Transplant, 27, 1275, 10.1038/sj.bmt.1703056 Aversa, 2008, Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States., Bone Marrow Transplant, 41, 473, 10.1038/sj.bmt.1705966 Aversa, 2005, Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse., J Clin Oncol, 23, 3447, 10.1200/JCO.2005.09.117 Komanduri, 2007, Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing., Blood, 110, 4543, 10.1182/blood-2007-05-092130 Brown, 2008, Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution., Clin Immunol, 127, 286, 10.1016/j.clim.2008.02.008 Chen, 2006, Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies., Br J Haematol, 135, 524, 10.1111/j.1365-2141.2006.06330.x Bethge, 2006, Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity., Exp Hematol, 34, 1746, 10.1016/j.exphem.2006.08.009 Huang, 2006, Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies., Bone Marrow Transplant, 38, 291, 10.1038/sj.bmt.1705445 Lu, 2006, Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation., Blood, 107, 3065, 10.1182/blood-2005-05-2146 Ruggeri, 2002, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants., Science, 295, 2097, 10.1126/science.1068440 Davies, 2002, Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants: killer immunoglobulin-like receptor., Blood, 100, 3825, 10.1182/blood-2002-04-1197 Asai, 1998, Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation., J Clin Invest, 101, 1835, 10.1172/JCI1268 Wilhelm, 2003, Gammadelta T cells for immune therapy of patients with lymphoid malignancies., Blood, 102, 200, 10.1182/blood-2002-12-3665 Min, 2002, Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation., Blood, 99, 4592, 10.1182/blood.V99.12.4592 Rossi, 2002, Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease., Blood, 100, 682, 10.1182/blood.V100.2.682 Seggewiss, 2007, Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques., Blood, 110, 441, 10.1182/blood-2006-12-065623 Langner, 2008, Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients., Bone Marrow Transplant, 42, 275, 10.1038/bmt.2008.157 Levine, 2008, Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT)., Biol Blood Marrow Transplant, 14, 1017, 10.1016/j.bbmt.2008.06.013 Sutherland, 2008, Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade., Clin Cancer Res, 14, 1138, 10.1158/1078-0432.CCR-07-1784 Kelly, 2008, Keratinocyte growth factor and androgen blockade work in concert to protect against conditioning regimen-induced thymic epithelial damage and enhance T-cell reconstitution after murine bone marrow transplantation., Blood, 111, 5734, 10.1182/blood-2008-01-136531 Murphy, 1992, Immunologic and hematologic effects of neuroendocrine hormones: studies on DW/J dwarf mice., J Immunol, 148, 3799, 10.4049/jimmunol.148.12.3799 Chen, 2003, Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice., Exp Hematol, 31, 953, 10.1016/S0301-472X(03)00196-6 Knyszynski, 1992, Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow., Brain Behav Immun, 6, 327, 10.1016/0889-1591(92)90032-J Napolitano, 2008, Growth hormone enhances thymic function in HIV-1-infected adults., J Clin Invest, 118, 1085 Krauss, 2008, Tyrosine kinase inhibition with sunitinib facilitates thymic engraftment by modulating thymic niche accessibility [abstract]., Blood, 112, 10.1182/blood.V112.11.72.72 Faivre, 2007, Molecular basis for sunitinib efficacy and future clinical development., Nat Rev Drug Discov, 6, 734, 10.1038/nrd2380 Nikolich-Zugich, 2008, Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections., Nat Rev Immunol, 8, 512, 10.1038/nri2318 Radtke, 2004, Notch regulation of lymphocyte development and function., Nat Immunol, 5, 247, 10.1038/ni1045 Schmitt, 2002, Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro., Immunity, 17, 749, 10.1016/S1074-7613(02)00474-0 Zakrzewski, 2006, Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation., Nat Med, 12, 1039, 10.1038/nm1463 Delaney, 2008, Notch-mediated expansion of human cord blood progenitor cells results in rapid myeloid reconstitution in vivo following myeloablative cord blood transplantation [abstract]., Blood, 112, 10.1182/blood.V112.11.212.212 Soiffer, 1992, Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation., Blood, 79, 517, 10.1182/blood.V79.2.517.517 Perillo, 2002, Administration of low-dose interleukin-2 plus G-CSF/EPO early after autologous PBSC transplantation: effects on immune recovery and NK activity in a prospective study in women with breast and ovarian cancer., Bone Marrow Transplant, 30, 571, 10.1038/sj.bmt.1703687 Slavin, 1996, Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation., Blood, 87, 2195, 10.1182/blood.V87.6.2195.bloodjournal8762195 Nadal, 2004, Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions., Exp Hematol, 32, 218, 10.1016/j.exphem.2003.10.016 Mackall, 2001, IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation., Blood, 97, 1491, 10.1182/blood.V97.5.1491 Fry, 2001, A potential role for interleukin-7 in T-cell homeostasis., Blood, 97, 2983, 10.1182/blood.V97.10.2983 Bolotin, 1996, Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7., Blood, 88, 1887, 10.1182/blood.V88.5.1887.1887 Alpdogan, 2001, Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease., Blood, 98, 2256, 10.1182/blood.V98.7.2256 Alpdogan, 2003, IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation., J Clin Invest, 112, 1095, 10.1172/JCI200317865 Chung, 2007, Prevention of graft-versus-host disease by anti IL-7Ralpha antibody., Blood, 110, 2803, 10.1182/blood-2006-11-055673 Sinha, 2002, Interleukin 7 worsens graft-versus-host disease., Blood, 100, 2642, 10.1182/blood-2002-04-1082 Storek, 2003, Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys., Blood, 101, 4209, 10.1182/blood-2002-08-2671 Sportès, 2008, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets., J Exp Med, 205, 1701, 10.1084/jem.20071681 Katsanis, 1996, IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice., Transplantation, 62, 872, 10.1097/00007890-199609270-00031 Klebanoff, 2004, IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells., Proc Natl Acad Sci U S A, 101, 1969, 10.1073/pnas.0307298101 Rubinstein, 2002, Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells., J Immunol, 169, 4928, 10.4049/jimmunol.169.9.4928 Sun, 2006, Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice., Clin Vaccine Immunol, 13, 227, 10.1128/CVI.13.2.227-234.2006 Lin, 2006, Effect of interleukin-15 on alloreactivity in umbilical cord blood., Transpl Immunol, 16, 112, 10.1016/j.trim.2006.04.002 Peggs, 2003, Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines., Lancet, 362, 1375, 10.1016/S0140-6736(03)14634-X Comoli, 2007, Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation., Am J Transplant, 7, 1648, 10.1111/j.1600-6143.2007.01823.x Thorne, 2006, Synergistic antitumor effects of immune cell-viral biotherapy., Science, 311, 1780, 10.1126/science.1121411 Einsele, 2003, Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option?, Lancet, 362, 1343, 10.1016/S0140-6736(03)14673-9 Riddell, 2006, Adoptive transfer of allogeneic antigen-specific T cells., Biol Blood Marrow Transplant, 12, 9, 10.1016/j.bbmt.2005.10.025 Kapp, 2009, Cellular therapy to control tumor progression., Curr Opin Hematol, 16, 437, 10.1097/MOH.0b013e32832f57d4 Schmaltz, 2002, T cells require TRAIL for optimal graft-versus-tumor activity., Nat Med, 8, 1433, 10.1038/nm1202-797 Zheng, 2008, Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease., Blood, 111, 2476, 10.1182/blood-2007-08-109678 Marktel, 2003, Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation., Blood, 101, 1290, 10.1182/blood-2002-08-2351 Ciceri, 2005, Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation., Cytotherapy, 7, 144, 10.1080/14653240510018136 Kaneko, 2009, IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes., Blood, 113, 1006, 10.1182/blood-2008-05-156059 Walter, 1995, Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor., N Engl J Med, 333, 1038, 10.1056/NEJM199510193331603 Rauser, 2004, Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants., Blood, 103, 3565, 10.1182/blood-2003-09-3056 Cobbold, 2005, Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers., J Exp Med, 202, 379, 10.1084/jem.20040613 Leen, 2009, Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation., Blood, 114, 4283, 10.1182/blood-2009-07-232454 Berger, 2009, Adoptive transfer of virus-specific and tumor-specific T cell immunity., Curr Opin Immunol, 21, 224, 10.1016/j.coi.2009.02.010 Kleihauer, 2001, Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells., Br J Haematol, 113, 231, 10.1046/j.1365-2141.2001.02681.x Einsele, 2008, CMV-specific T cell therapy., Blood Cells Mol Dis, 40, 71, 10.1016/j.bcmd.2007.07.002 Nguyen, 2008, The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation., Blood, 111, 945, 10.1182/blood-2007-07-103895 Riley, 2009, Human T regulatory cell therapy: take a billion or so and call me in the morning., Immunity, 30, 656, 10.1016/j.immuni.2009.04.006 Davies, 2008, Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity., Transplantation, 86, 854, 10.1097/TP.0b013e3181861b6c Amrolia, 2005, Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation., Cytotherapy, 7, 116, 10.1080/14653240510018181 Norde, 2009, Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells., Blood, 113, 2312, 10.1182/blood-2008-04-153825 van Bergen, 2007, Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene., Blood, 109, 4089, 10.1182/blood-2006-08-043935 Passweg, 2004, Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation., Leukemia, 18, 1835, 10.1038/sj.leu.2403524 Ruggeri, 1999, Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation., Blood, 94, 333, 10.1182/blood.V94.1.333.413a31_333_339 Le Blanc, 2007, Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells., Leukemia, 21, 1733, 10.1038/sj.leu.2404777 Macmillan, 2009, Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial., Bone Marrow Transplant, 43, 447, 10.1038/bmt.2008.348 Sudres, 2006, Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice., J Immunol, 176, 7761, 10.4049/jimmunol.176.12.7761 Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation., Blood, 107, 1484, 10.1182/blood-2005-07-2775 Zangi, 2008, Mesenchymal stem cells (MSC) are not intrinsically immune privileged: direct demonstration in TCR transgenic mice and by imaging of allogeneic luciferase+ MSC in immune competent vs immune deficient mice [abstract]., Blood, 112, 10.1182/blood.V112.11.549.549 Woiciechowsky, 2001, Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia., Leukemia, 15, 246, 10.1038/sj.leu.2402013 Vago, 2009, Loss of mismatched HLA in leukemia after stem-cell transplantation., N Engl J Med, 361, 478, 10.1056/NEJMoa0811036 Molldrem, 2003, Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells., J Clin Invest, 111, 639, 10.1172/JCI200316398 Ratanatharathorn, 2009, Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects., Cancer Treat Rev, 35, 653, 10.1016/j.ctrv.2009.07.004 Koreth, 2009, Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review., Biol Blood Marrow Transplant, 15, 1502, 10.1016/j.bbmt.2009.07.016 Yong, 2009, Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib., Blood, 113, 875, 10.1182/blood-2008-05-158253 Kröger, 2009, Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma., Exp Hematol, 37, 791, 10.1016/j.exphem.2009.03.008